PYC pyc therapeutics limited

Ann: Polycystic Kidney Disease Program Investor Presentation, page-8

  1. 220 Posts.
    lightbulb Created with Sketch. 54
    My read on this is that patients who have severe disease will still prove difficult to treat as the increased gene expression from PYCs drug won't make up for the inheritant deficit in those patients. At this stage, based on the deck, it looks good if you have mild or lightly moderate disease.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.25
Change
-0.055(4.23%)
Mkt cap ! $726.1M
Open High Low Value Volume
$1.26 $1.26 $1.24 $173.1K 139.2K

Buyers (Bids)

No. Vol. Price($)
3 33352 $1.24
 

Sellers (Offers)

Price($) Vol. No.
$1.30 7691 1
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.